(Q45388986)

14 December 2017

title

Targeting Marek's disease virus by RNA interference delivered from a herpesvirus vaccine (English)

1 reference

14 December 2017

1 reference

5

1 reference

14 December 2017

Luke S Lambeth

1

1 reference

14 December 2017

Yuguang Zhao

series ordinal

2

1 reference

14 December 2017

Lorraine P Smith

series ordinal

3

1 reference

14 December 2017

Lydia Kgosana

series ordinal

4

1 reference

14 December 2017

language of work or name

English

0 references

publication date

31 October 2008

1 reference

14 December 2017

1 reference

14 December 2017

volume

27

1 reference

14 December 2017

issue

2

1 reference

14 December 2017

page(s)

298-306

1 reference

Differential attenuation of the induction by Marek's disease virus of transient paralysis and persistent neurological disease: a model for pathogenesis studies

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Protective efficacy of Marek's disease vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Marek's disease: the continuing struggle between pathogen and host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Evolution of Marek's disease -- a paradigm for incessant race between the pathogen and the host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

How cells respond to interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

A system for stable expression of short interfering RNAs in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Multiple, dispersed human U6 small nuclear RNA genes with varied transcriptional efficiencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Usage of putative chicken U6 promoters for vector-based RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Characterization and comparison of chicken U6 promoters for the expression of short hairpin RNAs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Comparison of bovine RNA polymerase III promoters for short hairpin RNA expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Interfering with hepatitis C virus RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Inhibition of gammaherpesvirus replication by RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Inhibition of the Epstein-Barr virus lytic cycle by Zta-targeted RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Inhibition of herpesvirus-6B RNA replication by short interference RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Inhibition of human cytomegalovirus replication by small interfering RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Inhibition of Anatid Herpes Virus-1 replication by small interfering RNAs in cell culture system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Identification of microRNAs of the herpesvirus family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Absolute quantitation of Marek's disease virus genome copy number in chicken feather and lymphocyte samples using real-time PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Functional knockdown of neuropilin-1 in the developing chick nervous system by siRNA hairpins phenocopies genetic ablation in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

RCAS-RNAi: a loss-of-function method for the developing chick retina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Marek's disease vaccines: a solution for today but a worry for tomorrow?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Defining the optimal parameters for hairpin-based knockdown constructs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Design and cloning strategies for constructing shRNA expression vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

The Early Pathogenesis of Turkey Herpesvirus Infection in Chickens and Turkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

Replication-competent retrovirus vectors for the transfer and expression of gene cassettes in avian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.10.023

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2008.10.023

1 reference

14 December 2017

1 reference